Cardax Appoints Former Novartis, Bristol-Myers Squibb, and Boehringer Ingelheim Executives as Directors
Business Wire - Tue Jun 17, 7:01AM CDT
Cardax, Inc. ("Cardax"
Cardax, Inc. - "Astaxanthin for the Treatment of Osteoarthritis, a Large Unmet Medical Need"
ACCESSWIRE - Tue Jun 10, 7:32AM CDT
New York, NY / June 10, 2014 / Cardax, Inc. (OTCQB: CDXI) today published a new blog post on The Chairman's Blog, written by the Company's Vice President of Research, Dr. Timothy J. King. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
Cardax, Inc. - "Nutraceuticals as Pharmaceuticals: Disruptive New Therapeutics from Cardax"
ACCESSWIRE - Wed May 21, 9:18AM CDT
New York, NY / May 21, 2014 / Cardax, Inc. (OTCQB: CDXI) today published a new blog post on The Chairman's Blog, written by the Company's Chief Scientific Officer, Gilbert M. Rishton, Ph.D. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.